Humatica underscores growth in the DACH region with new office in Munich

In addition to London and Zurich, Humatica will open a third European office in Munich in January 2023. This will enable the firm to serve existing and new clients in the DACH region more effectively.

The new Munich office will be led by longstanding Operating Partner Andreas Knobloch, with the recent appointment of Partner Dr. Jochen Schilcher adding further private equity advisory competence to Humatica’s capabilities in Germany.

Andreas has more than 20 years’ international business leadership and advisory experience with private equity backed portfolio companies, Silicon Valley start-ups and large corporates. He was one of the original Humatica team members and has advised hundreds of private equity clients and their portfolio companies on strategic transformation and organizational effectiveness.

Jochen brings more than 20 years of management advisory experience serving leading global corporations, private equity funds, SMEs, and family businesses – focusing on strategy, business model innovation, organizational effectiveness & efficiency. He has deep experience with large-scale transformation and performance improvement programs.

Andreas Knobloch says: “It’s an exciting time for Humatica.  Jochen and I will be working closely together to develop our presence in the German market. The new office will enable us to expand our business with existing German clients and develop new relationships in this attractive European market.”

“We are looking to further expand the Munich team with new hires at all levels. As a specialist advisor working at the highest level with demanding PE funds and their entrepreneurial portfolio companies, we offer a unique opportunity.”

Andros Payne, Humatica Managing Partner notes: “Our new offices in the heart of Munich will allow us to serve more funds and portfolio companies in the attractive DACH region while strengthening our global offering.”

To download the news release in PDF format, klicken Sie hier.